Zscaler stock climbed after the cybersecurity firm reported earnings, revenue and billings for its fiscal first quarter that topped Wall Street targets. Revenue guidance for ZS stock in the January quarter also came in above views.


San Jose, Calif-based Zscaler (ZS) reported earnings after the market close on Tuesday. Zscaler earnings were 14 cents a share on an adjusted basis, the same as a year earlier. Revenue rose 62% to $230.5 million, the cybersecurity company said.

Analysts expected Zscaler earnings of 12 cents per share on sales of $212 million. Also, billings rose 71% to $247.7 million, blowing past estimates of $204 million.

For the current quarter ending in January, the company expects earnings of 11 cents a share amid higher investments in its sales force. Analysts had projected earnings of 12 cents a share. Zscaler expects revenue of $241 million vs. estimates of $224.8 million.

Zscaler Stock Holds High Relative Strength Rating

Shares in Zscaler rose 5.3% to 365.50 during extended trading on the stock market today. The cybersecurity stock had advanced 68% in 2021 just ahead of the Zscaler earnings report.

Zscaler said it plans to expand product integrations with CrowdStrike Holdings (CRWD), which reports earnings on Wednesday.

ZS stock owned a Relative Strength Rating of 95 out of a best-possible 99, according to IBD Stock Checkup.

Zscaler stock jumped in 2020 amid a corporate shift to remote work during the early coronavirus crisis. That increased demand for its web security gateways that inspect customers’ data traffic for malware.

If you’re new to IBD, consider taking a look at its stock trading system and CAN SLIM basics. Recognizing chart patterns is one key to the investment guidelines.

IBD offers a broad range of growth stock lists, such as Leaderboard. Investors also can create watchlists, find companies nearing a buy point, or develop custom screens at IBD MarketSmith.

Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.

How To Use The 10-Week Moving Average For Buying And Selling

How This IBD Tool Simplifies The Search For Top Stocks

Find Compelling Growth Stocks With IBD’s Stock Of The Day

See IBD Stock Lists & Get Pass/Fail Ratings For All Your Stocks With IBD Digital


By James Carter

A Senior writer & Editor, James is a postgraduate in biotechnology and has an immense interest in following news developments. Quiet by nature, he is an avid Lacrosse player. He is responsible for handling the office staff writers and providing them with the latest updates happenings in the world. He writes for almost all sections of Editorials 24.